You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Glaxosmithkline Pharmaceuticals Ltd"

Glaxosmithkline Pharmaceuticals Ltd Compliance Of Clause 40(9) Of The Listing Obligations And Disclosure Requirements Regulations 2015 (

  • 10/10/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Statement Of Investors Complaint For Quarter Ended September 2017

  • 06/10/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Compliance Certificate For Half Year Ended September 2017

  • 06/10/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd October 25 2017

  • 05/10/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Closure of Trading Window

  • 03/10/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Meeting Updates

  • 22/09/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Analyst / Investor Meet ? Intimation

  • 01/09/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Analyst / Investor Meet ? Intimation

  • 18/08/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Press Release

  • 26/07/2017
  • |
  • bse

Glaxosmithkline Pharmaceuticals Ltd Outcome of AGM

  • 26/07/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Un-Audited Results For Quarter Ended June 30 2017

  • 25/07/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Un-Audited Results For Quarter Ended June 30 2017

  • 25/07/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Updates

  • 14/07/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Investors Complaints For Quarter Ended June 30 2017

  • 13/07/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Board Meeting On 25Th July 2017

  • 03/07/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Closure of Trading Window

  • 29/06/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd AGM Notice

  • 29/06/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Revised Financial Results Quarter And Year March 2017

  • 02/06/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Intimation Of Schedule Of Analyst / Institutional Investor Meetings Under The Listing Regulations

  • 01/06/2017
  • |
  • bse

Glaxosmithkline Pharma Ltd Updates

  • 24/05/2017
  • |
  • bse